Womens Health Investment Outlook 2026

Global distribution of women’s health capital flows (2020–2025) – funding events grouped by the geographic location (city) of the funded and/or acquired companyFIGURE 6 Source: Pitchbook, CapIQ, Crunchbase Boston Consulting Group Between 2020 and 2025, there were just over 500 exit events (instances where investors realized returns through company sales or public listings) identified in women’s health, the majority (approximately 80%) through M&A and the remainder through initial public offerings (IPOs). Roughly 40% of these exits were for women’s health-specific companies. While women’s health accounts for a small portion of total healthcare exits (approximately 4%), the proportion of exits to overall funding events is consistent with the broader healthcare market. Within women’s health-specific companies, M&A activity was led by reproductive care delivery, followed by maternal care delivery and consumer reproductive health. Among IPOs, women’s cancer therapeutics was the most prevalent subsector. Data on identified capital flows indicates that returns in women’s health are generally in line with those in the overall healthcare market.Beyond the aggregate data, several proof points illustrate what is possible when capital flows into women’s health (see Box 1): a prenatal and oncology diagnostics company scaled with reimbursement-backed recurring revenues; a strategic acquirer paid a multibillion-dollar sum for a women’s pelvic health asset; a PE firm pursued a category leader in diagnostics and breast health with a take-private offer; and a biopharma company focused on women’s health conditions delivered competitive public-to-private returns. These examples demonstrate that women’s health can deliver the growth stories and ROI investors seek, while also revealing the conditions that enable success – credible reimbursement pathways, strategic acquisition interest, institutional participation and innovation that addresses clear clinical and economic need.2.2 Signals of investor success Circle size represents total capital raised by city ($B) $0B $10B $20B $30B $45B Broader -focused companies Women-specific companies Women’s Health Investment Outlook 16